The Middle East & Africa poultry vaccines market was valued at US$ 68.09 million in 2023 and is expected to reach US$ 119.87 million by 2031; it is estimated to record a CAGR of 7.3% from 2023 to 2031.
According to the US Department of Agriculture (USDA) report, poultry has become the most consumed livestock commodity worldwide in the past two decades, particularly in developing and emerging markets. Also, poultry is expected to remain the world's largest imported livestock commodity by volume in the next 10 years as per the same USDA report. The demand for poultry products and imports is rising worldwide. As rising disposable incomes, consumers shift toward purchasing animal-based poultry products comprising high content of proteins, specifically chicken. With rapid urbanization in many developing economies and emerging markets such as Southeast Asia and Sub-Saharan Africa, poultry products provide consumers with an affordable option for purchase as poultry products comprise high protein content and are more readily available as compared to other meat-based products that are expensive. To match the demand and supply of poultry products, several countries are focusing on domestic poultry production. Further, from 2001 to 2021, global poultry imports rose to an average of 4% year-on-year (y-o-y), reaching 14.2 million metric tons of production in 2021. With poultry products remaining high in demand worldwide and countries focusing on domestic livestock production, the demand for vaccination is also growing. Thus, the growing poultry industry fuels the poultry vaccines market growth.
Middle East and Africa region is divided into main countries such as Saudi Arabia, South Africa, UAE, and Rest of Middle East & Africa. In Middle East and Africa region, Saudi Arabia accounts major share for poultry vaccines market. Rising consumption pattern of protein source food is the most influential factor responsible for market growth.
The Middle East & Africa poultry vaccines market is categorized into type, technology, dosage form, disease, route of administration, end user, and country.
Based on type, the Middle East & Africa poultry vaccines market is bifurcated into broiler and layer. The broiler segment held a larger market share in 2023.
In terms of technology, the Middle East & Africa poultry vaccines market is categorized into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held the largest market share in 2023.
By dosage form, the Middle East & Africa poultry vaccines market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered form vaccines. The liquid vaccines segment held the largest market share in 2023.
Based on disease, the Middle East & Africa poultry vaccines market is categorized into avian influenza, infectious bronchitis, Marek's disease, avian salmonellosis, infectious bursal disease (IBD), Newcastle disease, and others. The Newcastle disease segment held the largest market share in 2023.
In terms of route of administration, the Middle East & Africa poultry vaccines market is segmented into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment held the largest market share in 2023.
Based on end user, the Middle East & Africa poultry vaccines market is segmented into poultry farms & hatchery, veterinary hospitals, and poultry vaccination enters & clinics. The poultry farms & hatchery segment held the largest market share in 2023.
By country, the Middle East & Africa poultry vaccines market is segmented into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. South Africa dominated the Middle East & Africa poultry vaccines market share in 2023.
Boehringer Ingelheim International GmbH, Zoetis Inc, Phibro Animal Health Corp, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc, Merck KGaA, Ceva, and Vaccinova AB. are some of the leading companies operating in the Middle East & Africa poultry vaccines market.
Strategic insights for the Middle East & Africa Poultry Vaccines provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 53.162 Million |
Market Size by 2028 | US$ 67.201 Million |
Global CAGR (2021 - 2028) | 3.4% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Type
|
Regions and Countries Covered | Middle East and Africa
|
Market leaders and key company profiles |
The geographic scope of the Middle East & Africa Poultry Vaccines refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The Middle East & Africa Poultry Vaccines Market is valued at US$ 53.162 Million in 2021, it is projected to reach US$ 67.201 Million by 2028.
As per our report Middle East & Africa Poultry Vaccines Market, the market size is valued at US$ 53.162 Million in 2021, projecting it to reach US$ 67.201 Million by 2028. This translates to a CAGR of approximately 3.4% during the forecast period.
The Middle East & Africa Poultry Vaccines Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Poultry Vaccines Market report:
The Middle East & Africa Poultry Vaccines Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East & Africa Poultry Vaccines Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East & Africa Poultry Vaccines Market value chain can benefit from the information contained in a comprehensive market report.